Neurogene Inc.

NASDAQ:NGNE

Biotechnology

Healthcare
$23.14 +2.47%

+$0.76 today

Market cap
$365.67M
Beta
2.04
P/E (TTM)
-7.1
EPS (TTM)
-$4.42
52W Low $14.65High $37.27

Volume 0.25M

Average 0.16M

NGNE Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Neurogene Inc.NASDAQ: NGNE

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares of 22.31M shares rose 6.2% year over year, behind the +14.7% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 44.0% from the prior quarter. Over 3 fiscal years it compounded at +18.2% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +6.2% toward the trailing-twelve-month pace of +14.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
22.31M+44.0% QoQ
Last fiscal yearDec 2025
21.17M+20.5% YoY
LTMMar 2026
20M+14.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.2%——
1 year+20.5%——
3-year CAGR+18.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
21.17M USD
Year-over-year change
+20.5%
4-year CAGR
-21.3%

Weighted Avg Shares vs competitors

How NGNE compares with its peers on the latest reported figures

  • NGNE's LTM Mar 2026 weighted avg shares of 20M shares is the lowest of the 8 companies compared; the peer median is 65.52M shares.
  • Its year-over-year change of +14.7% is the 3rd highest of 8, against a peer median of +7.9%.
  • Over three fiscal years its annual growth of +18.2% compares with a peer median of +21.2%.
NGNE Competitors Peer median
Weighted Avg Shares for NGNE and competitors
Company Period LTM YoY 3-year CAGR
TSHATaysha Gene Therapies, Inc.LTM Jun 2026352.17M +35.4%+93.8%
ALECAlector, Inc.LTM Mar 2026104.14M +6.5%+7.7%
MGTXMeiraGTx Holdings plcLTM Mar 202680.99M +13.7%+21.2%
LXEOLexeo Therapeutics, Inc. Common StockLTM Mar 202665.52M +98.2%+28.7%
FDMT4D Molecular Therapeutics, Inc.LTM Mar 202659.51M +7.9%+21.4%
VYGRVoyager Therapeutics, Inc.LTM Mar 202658.91M +1.6%+15.2%
DSGNDesign Therapeutics, Inc.LTM Mar 202658.14M +2.6%+1.0%
NGNENeurogene Inc.LTM Mar 202620M +14.7%+18.2%
Peer median (excluding NGNE) 65.52M+7.9%+21.2%

Competitors are the stored peer set for NGNE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue000925K0
Cost of Revenue42.26M3.2M3.26M3.25M3.19M
Gross Profit(42.26M)(3.2M)(3.26M)(2.32M)(3.19M)
Gross Margin———-251.0%—
Research & Development42.26M47.51M44.39M60.92M75.01M
Selling, General & Admin8.27M9.01M11.19M22.61M25.13M
Operating Expenses8.27M53.32M52.32M80.28M100.02M
Depreciation & Amortization947K3.2M3.3M3.25M3.09M
EBITDA(49.57M)(51.99M)(33.01M)(71.89M)(87.25M)
EBITDA Margin———-7771.4%—
Operating Income(50.53M)(56.52M)(55.58M)(82.61M)(103.21M)
Operating Margin———-8930.3%—
Interest Income19K1.34M2.95M8.47M11.55M
Interest Expense02K12K12K5K
Other Income / Expenses17K1.33M19.27M7.46M12.86M
Income Before Tax(50.52M)(55.19M)(36.32M)(75.14M)(90.35M)
Pre-Tax Margin———-8123.7%—
Income Tax Expense00000
Net Income(50.52M)(55.19M)(36.32M)(75.14M)(90.35M)
Net Margin———-8123.7%—
EPS (Basic)(0.92)(4.30)(2.83)(4.28)(4.24)
EPS (Diluted)(0.92)(4.30)(2.83)(4.28)(4.24)
Weighted Avg Shares55.04M12.82M12.82M17.57M21.17M
Weighted Avg Shares (Diluted)55.04M12.82M12.82M17.57M21.17M

Neurogene Inc.

NASDAQ:NGNE

Intrinsic Alpha fair value

Locked

Current Price

$23.14

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.